Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123172) titled 'Construction of a Clinical Prediction Model for Cardiotoxicity in Breast Cancer Chemotherapy and Targeted Therapy Based on Machine Learning' on April 22.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The Fifth Affiliated Hospital of Zhengzhou University
Condition:
cardiotoxicity
Intervention:
Cardiotoxicity group:No intervention
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-10
Target Sample Size: Cardiotoxicity group:50;Non-cardiotoxicity group:200;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.ht...